» Authors » Paul Nankivell

Paul Nankivell

Explore the profile of Paul Nankivell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 344
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hillier B, Waterboer T, Brooks J, Nankivell P, Agarwal R, Abou-Foul A, et al.
J Infect . 2025 Feb; 90(3):106438. PMID: 39922388
Objectives: Human papillomavirus (HPV) mediated oropharyngeal cancer (OPC) incidence has increased dramatically. Accurate oral HPV prevalence data are essential for assessing population epidemiology, vaccination and screening programmes. As oral rinse...
2.
Williamson A, Nankivell P, Abou-Foul A, Ahmed M, Mehanna H
Head Neck . 2025 Jan; PMID: 39781667
Background: The aim of this clinical survey was to assess variations in head and neck squamous cell carcinoma from an unknown primary (HNSCCUP) diagnostic practices across international centers. Methods: Clinical...
3.
Kenny-Jones M, Nankivell P, Mehanna H, Ozakinci G
Curr Oncol . 2024 Dec; 31(12):7586-7602. PMID: 39727682
Cancer care is evolving, and digital resources are being introduced to support cancer patients throughout the cancer journey. Logistical concerns, such as health literacy and the emotional experience of cancer,...
4.
Abou-Foul A, Dretzke J, Albon E, Kristunas C, Moore D, Karwath A, et al.
Front Oncol . 2024 Dec; 14:1478385. PMID: 39711957
Background: The limitations of the traditional TNM system have spurred interest in multivariable models for personalized prognostication in laryngeal and hypopharyngeal cancers (LSCC/HPSCC). However, the performance of these models depends...
5.
Dretzke J, Abou-Foul A, Albon E, Hillier B, Scandrett K, Price M, et al.
BMJ Open . 2024 Dec; 14(12):e090393. PMID: 39638589
Objectives: This systematic review aims to evaluate externally validated models for individualised prediction of recurrence or survival in adults treated with curative intent for oropharyngeal cancer. Design: Systematic review. Setting:...
6.
Jesani H, Hundle A, Nankivell P, Kalkat M
J Cardiothorac Surg . 2024 Nov; 19(1):621. PMID: 39497187
Background: Ingested dental prosthesis are susceptible to impaction in the gastrointestinal tract due to their sharp edges, size and contour. Delays in presentation arise from the lack of clear history...
7.
Mehanna H, Sidhu P, Madani G, Woolley R, Boelaert K, Nankivell P, et al.
Radiology . 2024 Oct; 313(1):e240705. PMID: 39404634
Background There is variable evidence and no randomized trials on the benefit of US elastography-guided fine-needle aspiration cytology (FNAC) over conventional US-guided FNAC alone for thyroid nodules. Purpose To compare...
8.
Mehanna H, Nankivell P, Boelaert K, Woolley R, Sharma N, Sidhu P, et al.
J Clin Endocrinol Metab . 2024 Oct; PMID: 39359050
Introduction: ElaTION is a large multi-centre pragmatic randomised controlled trial, performed in 18 secondary/tertiary hospitals across England, comparing elastography ultrasound-guided fine needle aspiration cytology (EUS-FNAC) with ultrasound-guided FNAC (US-FNAC) alone...
9.
Brooks J, Zheng Y, Hunter K, Willcox B, Dunn J, Nankivell P, et al.
Front Oncol . 2024 Sep; 14:1428741. PMID: 39328208
Background: The incidence of oropharyngeal cancer (OPC) is increasing, due mainly to a rise in Human Papilloma Virus (HPV)-mediated disease. HPV-mediated OPC has significantly better prognosis compared with HPV-negative OPC,...
10.
von Buchwald C, Jakobsen K, Fenger Carlander A, Tous S, Gronhoj C, Rasmussen J, et al.
Eur J Cancer . 2024 Sep; 211:114329. PMID: 39293346
Purpose: The assessment of p16INK4a (p16) in oropharyngeal squamous cell carcinoma (OPSCC) has been incorporated into tumor classification, as p16 has been shown to impact survival probability. However, a recent...